Glendale, AZNCT06173505Now EnrollingIRB Ready

Lung Cancer Clinical Trial in Glendale, AZ

Access cutting-edge lung cancer treatment through this clinical trial at a research site in Glendale. Study-provided care at no cost to qualified participants.

Sponsored by Xencor, Inc.

Quick Self-Assessment

See if you qualify for this Glendale location

Preparing your pre-screening questions...

Expert Care in Glendale

Access lung cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lung cancer treatment provided free

Apply for This Glendale Location

Check if you qualify for this lung cancer clinical trial in Glendale, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Glendale

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Glendale site if eligible
  4. 4Begin participation

About This Lung Cancer Study in Glendale

The purpose of this study is to identify the recommended dose of vudalimab to be used in combination with chemotherapy (Part 1) and to evaluate the efficacy and safety of vudalimab plus standard of care chemotherapy relative to pembrolizumab plus chemotherapy (Part 2) as first-line treatment in patients with nonsquamous non-small cell lung cancer (NSCLC).

Sponsor: Xencor, Inc.

Who Can Participate

Inclusion Criteria

Histologically confirmed, locally advanced (unresectable) or metastatic nonsquamous NSCLC
Documented absence of tumor activating EGFR mutation, ALK gene and ROS1 rearrangements, and alterations in any actionable driver oncogenes for which there are locally approved targeted first-line therapies
PD-L1 IHC testing documenting TPS \< 49%
No prior systemic treatment for advanced/metastatic NSCLC.
Measurable disease by RECIST 1.1
ECOG performance status score of 0 or 1
Life expectancy ≥ 3 months
Adequate liver, kidney, thyroid and bone marrow function Key

Exclusion Criteria

Have known active central nervous system metastases and/or carcinomatous meningitis. Patients with treated brain metastases may participate, provided they are radiologically stable
Active known or suspected autoimmune disease
Has any condition requiring systemic treatment with corticosteroids, prednisone equivalents, or other immunosuppressive medications within 14 days p

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Glendale?

Yes, this clinical trial (NCT06173505) has an active research site in Glendale, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Lung Cancer Treatment Options in Glendale, AZ

If you're searching for lung cancer treatment options in Glendale, AZ, this clinical trial (NCT06173505) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Glendale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all lung cancer clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Glendale, AZ

See all lung cancer clinical trials recruiting in Glendale — not just this study.

Browse Lung Cancer Trials in Glendale

Ready to Join in Glendale?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Glendale, AZ